Related Articles

• Bevacizumab to combat EGFR-TKI resistance in a patient with advanced non-small cell lung cancer harboring an EGFR mutation: A case report
• Synergistic interaction between sorafenib and gemcitabine in EGFR‑TKI‑sensitive and EGFR‑TKI‑resistant human lung cancer cell lines
• Transformation from adenocarcinoma to squamous cell carcinoma associated with long‑term administration of EGFR‑TKIs
• Eyelash trichomegaly following treatment with erlotinib in a non‑small cell lung cancer patient: A case report and literature review
• A retrospective study of the efficacy of combined EGFR‑TKI plus VEGF inhibitor/cytotoxic therapy vs. EGFR‑TKI monotherapy for PD‑L1‑positive EGFR‑mutant non‑small cell lung cancer: North Japan Lung Cancer Study Group 2202